Commentary

Prevention of stroke in patients with prior stroke or transient ischemic attack


 

References

Hypercoagulation

The utility of screening for factor V Leiden, protein C deficiency, antiphospholipid antibodies, or other thrombophilic states is unclear. Anticoagulation can be considered if a coagulation abnormality is found, and if anticoagulation is not used then antiplatelet therapy is recommended.

Bottom line

Maintaining a healthy stroke-free lifestyle after a stroke/TIA requires rapid identification of stroke risk factors. The 2014 American Heart Association/American Stroke Association secondary stroke recommendations including the use of antiplatelet agents, anticoagulation for patients with atrial fibrillation, control of hypertension and hypercholesterolemia, and other risk factors are important evidence-based approaches to decrease the risk of recurrent stroke.

Dr. Skolnik is associate director of the family medicine residency program at Abington (Pa.) Memorial Hospital and professor of family and community medicine at Temple University in Philadelphia. Dr. Mathew is a third-year resident in the family medicine residency program at Abington Memorial Hospital.

Pages

Recommended Reading

Systemic biologics might revolutionize the treatment of atopic dermatitis
MDedge Family Medicine
Secukinumab earns FDA approval for plaque psoriasis
MDedge Family Medicine
Medicaid pay bump linked to more new-patient appointments
MDedge Family Medicine
Permanent SGR fix faces funding hurdle
MDedge Family Medicine
Solidarity II
MDedge Family Medicine
Guidelines for drug treatment of obesity unveiled
MDedge Family Medicine
Tips on tics
MDedge Family Medicine
CDC: Opioid use high among reproductive age women
MDedge Family Medicine
Congress to doctors: How can we pay for SGR fix?
MDedge Family Medicine
Psychiatric diagnoses rank first and third among Medicaid admissions
MDedge Family Medicine